Jing Luo

2.2k total citations · 1 hit paper
86 papers, 1.4k citations indexed

About

Jing Luo is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jing Luo has authored 86 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Economics and Econometrics and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jing Luo's work include Pharmaceutical studies and practices (13 papers), Diabetes Treatment and Management (13 papers) and Diabetes Management and Research (12 papers). Jing Luo is often cited by papers focused on Pharmaceutical studies and practices (13 papers), Diabetes Treatment and Management (13 papers) and Diabetes Management and Research (12 papers). Jing Luo collaborates with scholars based in United States, China and United Kingdom. Jing Luo's co-authors include Aaron S. Kesselheim, Walid F. Gellad, Qian Lin, Jerry Avorn, Scott D. Rothenberger, Robert Feldman, Jeremy I. Schwartz, Pavithra Vijayakumar, Inmaculada Hernandez and Kasia J. Lipska and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Jing Luo

82 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US

2021 164 citations Jing Luo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jing Luo United States	21	425	222	172	158	156	86	1.4k
Maura McGuire United States	13	357 0.8×	223 1.0×	247 1.4×	213 1.3×	123 0.8×	44	1.5k
Steven B. Zeliadt United States	29	93 0.2×	362 1.6×	118 0.7×	178 1.1×	335 2.1×	129	2.6k
Oscar J. Ponce United States	19	283 0.7×	71 0.3×	101 0.6×	58 0.4×	177 1.1×	50	1.4k
Sundar S. Shrestha United States	20	322 0.8×	149 0.7×	250 1.5×	50 0.3×	169 1.1×	49	1.1k
Diego Rosselli Colombia	20	76 0.2×	171 0.8×	123 0.7×	77 0.5×	225 1.4×	218	1.5k
Carolyn Harley United States	14	66 0.2×	167 0.8×	126 0.7×	83 0.5×	146 0.9×	33	980
Elena Gospodarevskaya Australia	16	140 0.3×	127 0.6×	246 1.4×	94 0.6×	284 1.8×	28	1.8k
Darren Lau Canada	21	246 0.6×	264 1.2×	584 3.4×	338 2.1×	168 1.1×	54	2.1k
Peter Ueda Sweden	27	754 1.8×	169 0.8×	398 2.3×	316 2.0×	258 1.7×	78	2.6k
Nigel S. B. Rawson Canada	22	75 0.2×	322 1.5×	410 2.4×	160 1.0×	125 0.8×	85	2.0k

Countries citing papers authored by Jing Luo

Since Specialization

Citations

This map shows the geographic impact of Jing Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Luo more than expected).

Fields of papers citing papers by Jing Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Luo. The network helps show where Jing Luo may publish in the future.

Co-authorship network of co-authors of Jing Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Luo. A scholar is included among the top collaborators of Jing Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Luo. Jing Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Benjamin, et al.. (2024). Rural-Urban Disparities in the Uptake of New Diabetes Medications. Diabetes Spectrum. 38(1). 49–57. 1 indexed citations

Roy, Payel, et al.. (2024). Buprenorphine dispensing before and after the April 2021 X-Waiver exemptions: An interrupted time series analysis. International Journal of Drug Policy. 126. 104381–104381. 14 indexed citations

Yuan, Yihang, Weijie Sun, Jiaqi Xie, et al.. (2024). RNA nanotherapeutics for hepatocellular carcinoma treatment. Theranostics. 15(3). 965–992. 18 indexed citations

Roy, Payel, et al.. (2023). Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design. SHILAP Revista de lepidopterología. 6. 100135–100135. 6 indexed citations

White, Gretchen E., et al.. (2023). Real‐world weight‐loss effectiveness of glucagon‐like peptide‐1 agonists among patients with type 2 diabetes: A retrospective cohort study. Obesity. 31(2). 537–544. 39 indexed citations

Luo, Jing, Kwan Hur, Muriel Burk, et al.. (2023). Incidence Rates and Clinical Characteristics of Patients With Confirmed Myocarditis or Pericarditis Following COVID-19 mRNA Vaccination: Experience of the Veterans Health Administration Through 9 October 2022. Open Forum Infectious Diseases. 10(7). ofad268–ofad268. 2 indexed citations

Luo, Jing, Nico Gabriel, Mary T. Korytkowski, Inmaculada Hernandez, & Walid F. Gellad. (2022). Association of formulary restrictions and initiation of an SGLT2i or GLP1-RA among Medicare beneficiaries with type 2 diabetes. Diabetes Research and Clinical Practice. 187. 109855–109855. 8 indexed citations

Shao, Hui, Jingchuan Guo, Yongkang Zhang, et al.. (2022). Projected Impact of the Medicare Part D Senior Savings Model on Diabetes-Related Health and Economic Outcomes Among Insulin Users Covered by Medicare. Diabetes Care. 45(8). 1814–1821. 10 indexed citations

Luo, Jing, Robert Feldman, Scott D. Rothenberger, et al.. (2022). Incidence and Predictors of Primary Nonadherence to Sodium Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Agonists in a Large Integrated Healthcare System. Journal of General Internal Medicine. 37(14). 3562–3569. 12 indexed citations

10.

Wong, Rachel, et al.. (2022). Where Do Real-Time Prescription Benefit Tools Fit in the Landscape of High US Prescription Medication Costs? A Narrative Review. Journal of General Internal Medicine. 38(4). 1038–1045. 2 indexed citations

11.

Guo, Jingchuan, Jing Luo, William C. Cushman, et al.. (2022). A machine learning approach identifies modulators of heart failure hospitalization prevention among patients with type 2 diabetes: A revisit to the ACCORD trial. Journal of Diabetes and its Complications. 36(9). 108287–108287. 7 indexed citations

12.

Luo, Jing & Kheang Un. (2021). China's Role in the Cambodian People's Party's Quest for Legitimacy. Contemporary Southeast Asia. 43(2). 395–419. 5 indexed citations

13.

Basu, Sanjay, Hui Shao, Jing Luo, et al.. (2020). Estimates of insulin needs and dispensation given wastage, alternative glycemic targets, and non-insulin therapies in US populations with type 2 diabetes mellitus: A microsimulation study. Journal of Diabetes and its Complications. 35(4). 107839–107839. 3 indexed citations

14.

Zou, Jiaojiao, et al.. (2019). Cross-cultural adaption and validation of the Chinese version of the Child Food Neophobia Scale. BMJ Open. 9(8). e026729–e026729. 17 indexed citations

15.

Luo, Jing. (2017). Shadow Banking, Interest Rate Marketization and Bank Risk-Taking: An Empirical Study of the 40 Commercial Banks in China. Journal of Financial Risk Management. 6(1). 27–36. 4 indexed citations

16.

Kumar, Rajesh, Jing Luo, & Theodore H. Tulchinsky. (2016). Vitamin K supplementation to prevent hemorrhagic morbidity and mortality of newborns in India and China. World Journal of Pediatrics. 13(1). 15–19. 5 indexed citations

17.

Luo, Jing & Aaron S. Kesselheim. (2016). Protecting Pharmaceutical Patents and Test Data: How the Trans-Pacific Partnership Agreement Could Affect Access to Medicines in the US and Abroad. The AMA Journal of Ethic. 18(7). 727–735. 2 indexed citations

18.

Luo, Jing & Aaron S. Kesselheim. (2015). Evolution of insulin patents and market exclusivities in the USA. The Lancet Diabetes & Endocrinology. 3(11). 835–837. 19 indexed citations

19.

Luo, Jing, et al.. (2014). Antiretroviral drug expenditure, pricing and judicial demand: an analysis of federal procurement data in Brazil from 2004–2011. BMC Public Health. 14(1). 367–367. 19 indexed citations

20.

Luo, Shuqin, Jing Luo, & Anthony H. Cincotta. (1999). Chronic Ventromedial Hypothalamic Infusion of Norepinephrine and Serotonin Promotes Insulin Resistance and Glucose Intolerance. Neuroendocrinology. 70(6). 460–465. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact